Yunhong H. Huang
Guiyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A national, multicenter, retrospective study of human immunodeficiency virus infection-associated lymphoma in China.
Journal: Clinical and experimental medicine
Published: May 27, 2025
Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial.
Journal: Journal for immunotherapy of cancer
Published: October 03, 2024
A Visual Nomogram Survival Prediction Model in Acquired Immune Deficiency Syndrome (AIDS)-Related Diffuse Large B-Cell Lymphoma.
Journal: Journal of medical virology
Published: July 26, 2024
Tifcemalimab as monotherapy or in combination with toripalimab in patients with relapsed/refractory lymphoma: a Phase I trial.
Journal: Nature communications
Published: July 01, 2024
Clinical characteristics and outcomes of newly diagnosed patients with human immunodeficiency virus-associated Burkitt lymphoma: the Central and Western China AIDS lymphoma league 002 study (CALL-002 study).
Journal: Infectious agents and cancer
Published: August 26, 2023
Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 30, 2023
Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: The Central and Western China AIDS Lymphoma League 001 study (CALL-001 study).
Journal: Frontiers in immunology
Published: January 30, 2023
Remission of extranodal NK/T-cell lymphoma, nasal type, after SARS-CoV-2 vaccination.
Journal: British journal of haematology
Published: October 05, 2022
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera® ) in combination with CHOP in patients with previously untreated CD20-positive diffuse large B-cell lymphoma: A randomized, single-blind, phase III clinical trial.
Journal: Hematological oncology
Published: February 28, 2022
Clinical characteristics and analysis of prognostic factors of 222 patients diagnosed with Hodgkin's lymphoma
Journal: Zhonghua yi xue za zhi
Published: December 26, 2019
Study of L-Asparaginase, Vincristine, and Dexamethasone Combined With Intensity-modulated Radiation Therapy in Early-Stage Nasal NK/T-Cell Lymphoma.
Journal: American journal of clinical oncology
Published: November 26, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026